Key facts
- This page summarizes Robert Janssen's Form 4 filing for DYNAVAX TECHNOLOGIES CORP (DVAX).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 20 Feb 2025, 19:52.
Robert Janssen - 18 Feb 2025 Form 4 Insider Report for DYNAVAX TECHNOLOGIES CORP (DVAX)
- Reporting relationship
- SVP and CMO
- Issuer ticker
- DVAX
- Reported as of
- 18 Feb 2025
- Net transaction value
- -$52,250
- SEC form
- 4
- Accepted by SEC
- 20 Feb 2025, 19:52:33 UTC
- Prior SEC filing
- 18 Feb 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Robert Janssen
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Robert Janssen filed Form 4 for DYNAVAX TECHNOLOGIES CORP (DVAX) on 20 Feb 2025.
Change
- Previous filing in this sequence was filed on 18 Feb 2025.
- Current net transaction value: -$52,250.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
DVAX
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +11,904
- Change %
- +17%
- Price
- Shares after
- 81,526
- Date
- 18 Feb 2025
- Ownership
- Direct
- Footnotes
- F1
DVAX
transaction
Common Stock
Tax liability
- Transaction value
- $52,250
- Shares
- -4,041
- Change %
- -5%
- Price
- $12.93
- Shares after
- 77,485
- Date
- 18 Feb 2025
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
DVAX
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- Shares
- -11,904
- Change %
- -33%
- Price
- Shares after
- 23,806
- Date
- 18 Feb 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 11,904
- Exercise price
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 15, 2024.
Footnote F2
Shares withheld by Dynavax Technologies Corporation to satisfy tax withholding requirements on vesting of restricted stock units.